# Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease

> **NCT00003421** · PHASE3 · COMPLETED · sponsor: **Medical Research Council** · enrollment: 800 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** bleomycin sulfate
- **DRUG:** ABVD regimen
- **DRUG:** chlorambucil
- **DRUG:** dacarbazine
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** prednisolone
- **DRUG:** procarbazine hydrochloride
- **DRUG:** vinblastine sulfate
- **DRUG:** vincristine sulfate
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003421
- **Lead sponsor:** Medical Research Council
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-06
- **Primary completion:** —
- **Final completion:** 2005-11
- **Target enrollment:** 800 (ESTIMATED)
- **Last updated:** 2013-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003421, "Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00003421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*